Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Avalo Therapeutics
(AVTX) Q4 2025
Earnings
AVTX
Nov 6
Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-2.3
-1.59
-0.88
-0.17
Details
Expected EPS
-1.65835
Actual EPS
-2.19
Surprise EPS
-0.53
Surprise Percent
-32.06%
Description
Avalo Therapeutics (AVTX) has reported earnings of -2.19 per share for Q4 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login